Does simplification to dolutegravir-based dual regimens impact on the CD4+/CD8+ T-cell ratio?

AIDS. 2018 May 15;32(8):1083-1084. doi: 10.1097/QAD.0000000000001784.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-HIV Agents / administration & dosage*
  • Antiretroviral Therapy, Highly Active / methods*
  • CD4-CD8 Ratio*
  • Heterocyclic Compounds, 3-Ring / administration & dosage*
  • Humans
  • Oxazines
  • Piperazines
  • Pyridones
  • Treatment Outcome

Substances

  • Anti-HIV Agents
  • Heterocyclic Compounds, 3-Ring
  • Oxazines
  • Piperazines
  • Pyridones
  • dolutegravir